Market Overview:
The global platelet-rich plasma therapy market is expected to register a CAGR of 7.8% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising incidence of sports injuries, increasing demand for minimally invasive surgeries and growing awareness about platelet-rich plasma therapy. Based on type, the global platelet-rich plasma therapy market is segmented into pure PRP, leucocyte rich PRP and leukocyte rich fibrin (LPRF). Leucocyte rich PRP dominates the market owing to its ability to promote wound healing and reduce inflammation. Based on application, the global platelet-rich plasma therapy market is segmented into orthopedic surgery, dermatology surgery, cardiac muscle injury surgery, dental surgery and nerve injury surgery among others. Orthopedic surgeries account for a major share of the overall application segment owing to rising incidence of sports injuries across all age groups. North America dominates the global Platelet Rich Plasma Therapy Market followed by Europe due To high prevalence rate Of Sports Injuries in these regions .
Product Definition:
Platelet-rich plasma therapy is the process of injecting concentrated platelets into a wound or injured area. The platelets help to promote healing and tissue regeneration. Platelet-rich plasma therapy is considered an important treatment for sports injuries, chronic wounds, and other orthopedic conditions.
Pure PRP:
Pure PRP is a procedure that makes use of platelet-rich plasma to treat damaged bones, skin lesions, and joints. It's an off-label application but it has shown promising results in clinical trials thus far.
Leucocyte-rich PRP:
Platelet-rich plasma (PRP) is a new therapy that has gained tremendous popularity in the field of regenerative medicine. It is used to treat various disorders such as arthritis, bone degenerative diseases, and soft tissue injuries. The mechanism by which this procedure helps patients recover faster from surgery or illness is still unknown.
Application Insights:
Based on application, the global market is segmented into orthopedic, dental, cardiac muscle injury, nerve injury and others. The orthopedic segment held the largest share in 2017 owing to rising number of knee & hip replacement procedures across the globe. Platelet-rich plasma therapy is used for treating osteoarthritis as well as rheumatoid arthritis. It helps in reducing pain and inflammation by strengthening cartilage repair process at a cellular level.
The cardiac muscle injury segment is expected to witness fastest growth over forecast period due to rising incidence of heart attack & stroke among other injuries caused by blood clots in the heart valves or arteries which leads to death or permanent disability if untreated. Cardiac PRP therapy regenerates damaged cells and reduces scarring after myocardial infarction (MI).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare spending levels in this region. Moreover, growing demand for minimally invasive surgeries and increasing prevalence of orthopedic disorders are expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising medical tourism activities by various governments as well as private agencies. In addition, an increase in per capita income level and improvement in living standards have resulted into a rise in consumer disposable income which can be used for treatment purposes leading to regional expansion.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The increasing demand for minimally invasive surgeries is one of the key growth drivers for the Platelet-rich Plasma Therapy market. Minimally invasive surgeries are less traumatic and result in shorter recovery times as compared to traditional open surgery procedures. This has led to an increase in the adoption of Platelet-rich Plasma Therapy procedures across various surgical specialties.
- Rising prevalence of chronic diseases: The rising prevalence of chronic diseases such as arthritis, diabetes, and cancer is also fueling the growth of the Platelet-rich Plasma Therapy market. These diseases are characterized by inflammation and tissue damage, which can be effectively treated with Platelet-rich Plasma Therapy procedures.
- Growing awareness about benefits of Platelet-rich Plasma Therapy: There is a growing awareness about the benefits of Platelet-rich Plasma Therapy among healthcare professionals and patients alike. This is helping to drive its adoption as a treatment option for various medical conditions.
Scope Of The Report
Report Attributes
Report Details
Report Title
Platelet-rich Plasma Therapy Market Research Report
By Type
Pure PRP, Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF)
By Application
Orthopedic, Darmatology, Cardiac Muscle Injury, Dental, Nerve Injury, Others
By Companies
Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, Nuo Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Platelet-rich Plasma Therapy Market Report Segments:
The global Platelet-rich Plasma Therapy market is segmented on the basis of:
Types
Pure PRP, Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Orthopedic, Darmatology, Cardiac Muscle Injury, Dental, Nerve Injury, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Terumo
- Arthrex
- Zimmer Biomet
- DePuy Synthes
- EmCyte
- Regen Lab
- ISTO Biologics
- Cesca Therapeutics
- Weigao
- REV-MED
- Nuo Therapeutics
Highlights of The Platelet-rich Plasma Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pure PRP
- Leucocyte-rich PRP
- Leukocyte-rich Fibrin (L-PRF)
- By Application:
- Orthopedic
- Darmatology
- Cardiac Muscle Injury
- Dental
- Nerve Injury
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Platelet-rich Plasma Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Platelet-rich plasma therapy (PRP) is a treatment that uses blood drawn from the patient and treated with special enzymes to increase the number of platelets. Platelets are important because they help heal wounds. PRP is used to treat conditions such as arthritis, tendonitis, and chronic pain.
Some of the key players operating in the platelet-rich plasma therapy market are Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, Nuo Therapeutics.
The platelet-rich plasma therapy market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Platelet-rich Plasma Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Platelet-rich Plasma Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Platelet-rich Plasma Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Platelet-rich Plasma Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Platelet-rich Plasma Therapy Market Size & Forecast, 2018-2028
4.5.1 Platelet-rich Plasma Therapy Market Size and Y-o-Y Growth
4.5.2 Platelet-rich Plasma Therapy Market Absolute $ Opportunity
Chapter 5 Global Platelet-rich Plasma Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Platelet-rich Plasma Therapy Market Size Forecast by Type
5.2.1 Pure PRP
5.2.2 Leucocyte-rich PRP
5.2.3 Leukocyte-rich Fibrin (L-PRF)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Platelet-rich Plasma Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Platelet-rich Plasma Therapy Market Size Forecast by Applications
6.2.1 Orthopedic
6.2.2 Darmatology
6.2.3 Cardiac Muscle Injury
6.2.4 Dental
6.2.5 Nerve Injury
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Platelet-rich Plasma Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Platelet-rich Plasma Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Platelet-rich Plasma Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Platelet-rich Plasma Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Platelet-rich Plasma Therapy Market Size Forecast by Type
9.6.1 Pure PRP
9.6.2 Leucocyte-rich PRP
9.6.3 Leukocyte-rich Fibrin (L-PRF)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Platelet-rich Plasma Therapy Market Size Forecast by Applications
9.10.1 Orthopedic
9.10.2 Darmatology
9.10.3 Cardiac Muscle Injury
9.10.4 Dental
9.10.5 Nerve Injury
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Platelet-rich Plasma Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Platelet-rich Plasma Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Platelet-rich Plasma Therapy Market Size Forecast by Type
10.6.1 Pure PRP
10.6.2 Leucocyte-rich PRP
10.6.3 Leukocyte-rich Fibrin (L-PRF)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Platelet-rich Plasma Therapy Market Size Forecast by Applications
10.10.1 Orthopedic
10.10.2 Darmatology
10.10.3 Cardiac Muscle Injury
10.10.4 Dental
10.10.5 Nerve Injury
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Platelet-rich Plasma Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Platelet-rich Plasma Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Platelet-rich Plasma Therapy Market Size Forecast by Type
11.6.1 Pure PRP
11.6.2 Leucocyte-rich PRP
11.6.3 Leukocyte-rich Fibrin (L-PRF)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Platelet-rich Plasma Therapy Market Size Forecast by Applications
11.10.1 Orthopedic
11.10.2 Darmatology
11.10.3 Cardiac Muscle Injury
11.10.4 Dental
11.10.5 Nerve Injury
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Platelet-rich Plasma Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Platelet-rich Plasma Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Platelet-rich Plasma Therapy Market Size Forecast by Type
12.6.1 Pure PRP
12.6.2 Leucocyte-rich PRP
12.6.3 Leukocyte-rich Fibrin (L-PRF)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Platelet-rich Plasma Therapy Market Size Forecast by Applications
12.10.1 Orthopedic
12.10.2 Darmatology
12.10.3 Cardiac Muscle Injury
12.10.4 Dental
12.10.5 Nerve Injury
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Platelet-rich Plasma Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Platelet-rich Plasma Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Platelet-rich Plasma Therapy Market Size Forecast by Type
13.6.1 Pure PRP
13.6.2 Leucocyte-rich PRP
13.6.3 Leukocyte-rich Fibrin (L-PRF)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Platelet-rich Plasma Therapy Market Size Forecast by Applications
13.10.1 Orthopedic
13.10.2 Darmatology
13.10.3 Cardiac Muscle Injury
13.10.4 Dental
13.10.5 Nerve Injury
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Platelet-rich Plasma Therapy Market: Competitive Dashboard
14.2 Global Platelet-rich Plasma Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Terumo
14.3.2 Arthrex
14.3.3 Zimmer Biomet
14.3.4 DePuy Synthes
14.3.5 EmCyte
14.3.6 Regen Lab
14.3.7 ISTO Biologics
14.3.8 Cesca Therapeutics
14.3.9 Weigao
14.3.10 REV-MED
14.3.11 Nuo Therapeutics
